Correlation Between Exicure and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Exicure and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exicure and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exicure and SAB Biotherapeutics, you can compare the effects of market volatilities on Exicure and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exicure with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exicure and SAB Biotherapeutics.
Diversification Opportunities for Exicure and SAB Biotherapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Exicure and SAB is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Exicure and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Exicure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exicure are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Exicure i.e., Exicure and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Exicure and SAB Biotherapeutics
Given the investment horizon of 90 days Exicure is expected to generate 11.17 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Exicure is 10.56 times less risky than SAB Biotherapeutics. It trades about 0.19 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 2.51 in SAB Biotherapeutics on August 29, 2024 and sell it today you would earn a total of 4.32 from holding SAB Biotherapeutics or generate 172.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 83.33% |
| Values | Daily Returns |
Exicure vs. SAB Biotherapeutics
Performance |
| Timeline |
| Exicure |
| SAB Biotherapeutics |
Exicure and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exicure and SAB Biotherapeutics
The main advantage of trading using opposite Exicure and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exicure position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Exicure vs. Ikena Oncology | Exicure vs. Eliem Therapeutics | Exicure vs. HCW Biologics | Exicure vs. RenovoRx |
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |